- Cain SM. Acute lung injury: assessment of tissue oxygenation. Crit Care Clin 1986;2 (3): 537–550.
- Mullins RJ. Shock, electrolytes, and fluid. In Townsend CM Jr, ed. Sabiston Textbook of Surgery, 17th ed. Philadelphia: Saunders, 2004.
- Carson JL, Noveck H, Berlin JA, Gould SA. Mortality and morbidity in patients with very low postoperative Hb levels who decline blood transfusion. Transfusion 2002;42 (7): 812–818.
- Dutton RP, Carson JL. Indications for early red blood cell transfusion. J Trauma 2006;60 (6 Suppl): S35–S40.
- Rogers DM, Crookston KP. The approach to the patient who refuses blood transfusion. Transfusion 2006;46 (9): 1471–1477.
- Bodnaruk ZM, Wong CJ, Thomas MJ. Meeting the clinical challenge of care for Jehovah's Witnesses. Transfus Med Rev 2004;18 (2): 105–116.
- Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007;21 (1): 58–71.
- Vichinsky EP, Earles A, Johnson RA, Hoag MS, Williams A, Lubin B. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322 (23): 1617–1621.
- Schonewille H, Haak HL, van Zijl AM. RBC antibody persistence. Transfusion 2000;40 (9): 1127–1131.
- Reid ME, Olsson ML. Human blood group antigens and antibodies. In Hoffman R, ed. Hematology: Basic Principles and Practice, 4th ed. Philadelphia: Churchill Livingstone, 2004.
- Remmers PA, Speer AJ. Clinical strategies in the medical care of Jehovah's Witnesses. Am J Med 2006;119 (12): 1013–1018.
- Ferzli GS, Hurwitz JB, Fiorillo MA, Hayek NE, Dysarz FA, Kiel T. Laparoscopic splenectomy in a Jehovah's Witness with profound anemia. Surg Endosc 1997;11 (8): 850–851.
- Fowler RA, Rizoli SB, Levin PD, Smith T. Blood conservation for critically ill patients. Crit Care Clin 2004;20 (2): 313–324.
- Cothren C, Moore EE, Offner PJ, Haenel JB, Johnson JL. Blood substitute and erythropoietin therapy in a severely injured Jehovah's Witness. N Engl J Med 2002;346 (14): 1097–1098.
- Josephson CD, Hillyer CD. Transfusion of plasma derivatives: fresh-frozen plasma, cryoprecipitate, albumin, and immunoglobulins. In Hoffman R, ed. Hematology: Basic Principles and Practice, 4th ed. Philadelphia: Churchill Livingstone, 2004.
- Kickler TS. Principles of platelet transfusion therapy. In Hoffman R, ed. Hematology: Basic Principles and Practice, 4th ed. Philadelphia: Churchill Livingstone, 2004.
- Kulvatunyou N, Heard SO. Care of the injured Jehovah's Witness patient: case report and review of the literature. J Clin Anesth 2004;16 (7): 548–553.
- Dutton RP, Hess JR, Scalea TM. Recombinant factor VIIa for control of hemorrhage: early experience in critically ill trauma patients. J Clin Anesth 2003;15 (3): 184–188.
- Ballen J, Raabe M, Muirhead B. Aortic dissection and hypothermic arrest in a Jehovah's Witness patient: a case for recombinant factor VIIa? Can J Anaesth 2006;53 (4): 353–356.
- Furie B, Furie BC. Molecular basis of vitamin K-dependent gamma-car-boxylation. Blood 1990;75 (9): 1753–1762.
- Weibert RT, Le DT, Kayser SR, Rapaport SI. Correction of excessive anticoagulation with low-dose oral vitamin K1. Ann Intern Med 1997;126 (12): 959–962.
- Daniels G, Poole J, de Silva M, Callaghan T, MacLennan S, Smith N. The clinical significance of blood group antibodies. Transfus Med 2002;12 (5): 287–295.
- Jamdar S, Siriwardena AK. Strategic management of severe acute pancreatitis in the Jehovah's Witness. Int J Clin Pract 2005;59 (11): 1368–1370.
- Gannon CJ, Napolitano LM. Severe anemia after gastrointestinal hemorrhage in a Jehovah's Witness: new treatment strategies. Crit Care Med 2002;30 (8): 1893–1895.
- Rackow EC, Falk JL, Fein IA, Siegel JS, Packman MI, Haupt MT, Kaufman BS, Putnam D. Fluid resuscitation in circulatory shock: a comparison of the cardiorespiratory effects of albumin, hetastarch, and saline solutions in patients with hypovolemic and septic shock. Crit Care Med 1983;11 (11): 839–850.
- Horstick G, Lauterbach M, Kempf T, Bhakdi S, Heimann A, Horstick M, Meyer J, Kempski O. Early albumin infusion improves global and local hemodynamics and reduces inflammatory response in hemorrhagic shock. Crit Care Med 2002;30 (4): 851–855.
- Morisaki H, Bloos F, Keys J, Martin C, Neal A, Sibbald WJ. Compared with crystalloid, colloid therapy slows progression of extrapulmonary tissue injury in septic sheep. J Appl Physiol 1994;77 (3): 1507–1518.
- Hashem B, Dillard TA. A 44-year-old Jehovah's Witness with life-threatening anemia from uterine bleeding. Chest 2004;125 (3): 1151–1154.
- Akingbola OA, Custer JR, Bunchman TE, Sedman AB. Management of severe anemia without transfusion in a pediatric Jehovah's Witness patient. Crit Care Med 1994;22 (3): 524–528.
- Lichtenstein A, Eckhart WF, Swanson KJ, Vacanti CA, Zapol WM. Unplanned intraoperative and postoperative hemodilution: oxygen transport and consumption during severe anemia. Anesthesiology 1988;69 (1): 119–122.
- Streef C, Charpentier C, Audibert G, Laxenaire MC. Treatment of post-traumatic acute anemia by recombinant human erythropoietin in Jehovah's Witnesses. Ann Fr Anesth Reanim 1996;15 (8): 1199–1202.
- Nearman HS, Eckhauser ML. Postoperative management of a severely anemic Jehovah's Witness. Crit Care Med 1983;11 (2): 142–143.
- Oda J, Kuwagata Y, Nakamori Y, Noborio M, Hayakata T, Fujimi S, Sugimoto H. Mild hypothermia alters the oxygen consumption/delivery relationship by decreasing the slope of the supply-dependent line. Crit Care Med 2002;30 (7): 1535–1540.
- Tibbles PM, Edelsberg JS. Hyperbaric-oxygen therapy. N Engl J Med 1996;334 (25): 1642–1648.
- Van Meter KW. A systematic review of the application of hyperbaric oxygen in the treatment of severe anemia: an evidence-based approach. Undersea Hyperb Med 2005;32 (1): 61–83.
- Hart GB, Lennon PA, Strauss MB. Hyperbaric oxygen in exceptional blood-loss anemia. J Hyperb Med 1987;2: 205.
- Stark RD, Coatesworth AP, Tucker AG. Management of life-threatening epistaxis in a Jehovah's Witness. Int J Clin Pract 2003;57 (1): 60–61.
- McLoughlin PL, Cope TM, Harrison JC. Hyperbaric oxygen therapy in the management of severe acute anaemia in a Jehovah's Witness. Anaesthesia 1999;54 (9): 891–895.
- Natanson C, Kern SJ, Lurie P, Banks SM, Wolfe SM. Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. JAMA 2008;299 (19): 2304–2312.
- Keipert PE, Faithfull NS, Bradley JD, Hazard DY, Hogan J, Levisetti MS, Peters RM. Enhanced oxygen delivery by perflubron emulsion during acute hemodilution. Artif Cells Blood Substit Immobil Biotechnol 1994;22 (4): 1161–1167.
- Anton N, Hitzler JK, Kavanagh BP. Treatment of life-threatening posthaemorrhagic anaemia with cell-free haemoglobin solution in an adolescent Jehovah's Witness. Br J Haematol 2002;118 (4): 1183–1186.
- Cothren CC, Moore EE, Long JS, Haenel JB, Johnson JL, Ciesla DJ. Large volume polymerized haemoglobin solution in a Jehovah's Witness following abruptio placentae. Transfus Med 2004;14 (3): 241–246.
- Shulman IA, Petz LD. Red cell compatibility testing: clinical significance and laboratory methods. In Petz LD, ed. Clinical Practice of Transfusion Medicine, 3rd ed. New York: Churchill Livingston, 1996: 199–244.
- Woodcock BE, Walker S, Adams K. Haemolytic transfusion reaction— successful attenuation with methylprednisolone and high dose immunoglobulin. Clin Lab Haematol 1993;15 (1): 59–61.
- Kohan AI, Reybaud JF, Salamone HJ, Rey JA, Rey CE, Villaravid N, Papa S, Cyrulik Goldztein S, Calahonra R, Sanchez Avalos JC. Management of a severe transfusional problem in a patient with alloantibody to Kpb (K4). Vox Sang 1990;59 (4): 216–217.
- Villa MA, Coluccio E, Revelli Nicoletta, Drago F, Morelati F, Rebulla P. Successful transfusion of Kp (a-b+) red cells incompatible for auto anti-Kpb. Haematologica 2005;90 (1): 13–14.
- Win N, Doughty H, Telfer P, Wild BJ, Pearson TC. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001;41 (3): 323–328.
Baylor University Medical Center Proceedings
The peer-reviewed journal of Baylor Scott & White Health
Volume 22, 2009 - Issue 4